Medication info
Lobasto Tablet 5 mg (Rosuvastatin Calcium)

Lobasto Tablet 5 mg (Rosuvastatin Calcium)

Prescription medicationTablet
Ingredient · strength
Rosuvastatin Calcium›5.2mg / 1 tablet
Manufacturer / importer
HLB Pharma Co., Ltd.
Appearance
Yellow round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201502973 · Approved 2015.05.18 · Insurance code 647303070

Summary

Main use
Treatment of dyslipidemia, prevention of cardiovascular disease, and inhibition of the progression of atherosclerosis
Who uses it
Adults · Children
Adult dosage
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, regardless of meals. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response; it may be increased to a maximum of 20 milligrams per day. 3. Older adults: No dosage adjustment is required. 4. Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: Systemic exposure to rosuvastatin did not increase in patients with a Child-Pugh score of 7 or less, but it increased in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients.
Children's dosage
Aged 10 to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years: Safety and efficacy have not been established.

Ingredients

Manufacturer
HLB Pharma Co., Ltd.

Efficacy & effects

Treatment of dyslipidemia, prevention of cardiovascular disease, and inhibition of the progression of atherosclerosis

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • primary dysbetalipoproteinemia
  • coronary artery disease
  • elevated high-sensitivity C-reactive protein
  • hypertension
  • low HDL cholesterol levels
  • smoking
View approved original text

This medication is effectively used for hypercholesterolemia, a condition characterized by high cholesterol levels in the blood. It helps in cases where cholesterol control is difficult due to genetic factors, such as familial hypercholesterolemia. It is also recommended for patients with mixed hyperlipidemia who cannot manage their condition with diet and exercise alone, and it lowers total cholesterol and LDL cholesterol levels, thereby slowing the progression of atherosclerosis. It is used as an adjunct to dietary therapy in children aged 10 to 17 years who meet specific criteria. Additionally, it helps reduce the risk of stroke and myocardial infarction in patients with dysbetalipoproteinemia and those at high risk for cardiovascular disease. In summary, this medication is used for various forms of hypercholesterolemia and to reduce the risk of cardiovascular disease.

Dosage and Administration

Adult dosage

1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, regardless of meals. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response; it may be increased to a maximum of 20 milligrams per day. 3. Older adults: No dosage adjustment is required. 4. Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: Systemic exposure to rosuvastatin did not increase in patients with a Child-Pugh score of 7 or less, but it increased in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients.

Children's dosage

Aged 10 to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years: Safety and efficacy have not been established.

Precautions

This medication should not be used in certain patients. For example, individuals who are allergic to this drug, those with liver function problems, or those with muscle disorders should avoid taking it. Additionally, it is not safe to administer to patients with severely impaired kidney function, pregnant or nursing women, and women of childbearing age who do not use appropriate contraception. Individuals at higher risk of muscle-related side effects, such as those with slightly impaired kidney function, hypothyroidism, family history of muscle disorders, alcohol abuse, Asian descent, and those taking certain other medications, should avoid taking this drug in high doses and should exercise caution during use. This medication contains lactose and should not be used by patients with lactose intolerance or genetic lactose metabolism disorders. Patients who consume a lot of alcohol or have a history of liver disease should have liver function tests before taking this medication and should monitor their liver status regularly during treatment. If symptoms such as muscle pain, weakness, or cramps occur, notify healthcare professionals immediately, and blood tests may be necessary to check for muscle damage. Particularly, if muscle damage markers are elevated or if muscle symptoms are severe, it is advisable to discontinue the medication and consult a physician. This drug may raise blood sugar levels in some patients, so those at a risk for diabetes should regularly monitor their blood glucose levels. Additionally, rare side effects such as skin rashes, itching, severe allergic reactions, liver function abnormalities, and myopathy may occur during use, and if these symptoms appear, patients should inform their healthcare provider promptly. This medication can interact with many other drugs, so it is crucial to inform the doctor or pharmacist if taking other medications. Women who are pregnant or planning to become pregnant should not take this medication, and if pregnancy occurs while using it, treatment should be immediately discontinued. In the case of overdose, since there is no specific antidote, patients should go to the hospital immediately for appropriate treatment and assessment of liver function and muscle damage. Finally, this medication is known to have little effect on driving or operating machinery, but caution is advised due to the possibility of dizziness.

Side effects

Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ophthalmoplegia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), lichenoid drug rash, lupus-like syndrome, muscle rupture, arthralgia, immunologically mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, increased CK, increased AST, joint pain, fatigue, numbness, dysesthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, acute kidney failure, oliguria, increased serum creatinine

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a tightly closed container. It is essential to maintain the storage temperature between 1 to 30 degrees Celsius to keep the medication effective for an extended period.

Appearance and packaging

Appearance

Yellow round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.